Concomitant administration of MK-801 and desipramine enhances extracellular concentration of dopamine in the rat prefrontal cortex
- 1 October 1993
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 5 (1) , 75-76
- https://doi.org/10.1097/00001756-199310000-00019
Abstract
The interaction between the antidepressant drug desipramine and the non-competitive NMDA receptor antagonist MK-801 was investigated at the level of dopamine release in the rat prefrontal cortex. Peripheral administration of MK-801 (0.2 mg kg-1) or desipramine (10 mg kg-1) evoked weak enhancement of the extracellular dopamine concentration in the rat PFC. Desipramine and MK-801 given jointly in doses which by themselves evoked a mild alteration of dopamine outflow (10 mg and 0.2 mg kg-1 respectively) produced pronounced enhancement of the extracellular concentration of dopamine in the rat prefrontal cortex. It is suggested that the non-competitive NMDA receptor antagonist may enhance the efficacy of classical antidepressant drugs.Keywords
This publication has 0 references indexed in Scilit: